November 05, 2015
Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors
Media
November 03, 2015
Strongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference
November 03, 2015
CER-001: Analysis of clinical results to be presented at the American Heart Association Scientific Congress, on November 9, 2015 in Orlando, UNITED-STATES
November 02, 2015
Wilson Therapeutics Appoints Anders Martin-Löf as Chief Financial Officer
October 30, 2015
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 17 NOVEMBER 2015
October 27, 2015
NORDIC NANOVECTOR: POSTER PRESENTATION OF PRECLINICAL STUDIES COMPARING BETALUTIN® WITH Lu-177 CHIMERIC ANTI-CD37 ANTIBODY RADIONUCLIDE CONJUGATE
October 21, 2015
NORDIC NANOVECTOR: RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2015
October 20, 2015
WILSON THERAPEUTICS APPOINTS ANDREW KAY AS CHAIRMAN
October 16, 2015
Strongbridge Biopharma plc Announces Pricing of Its Initial U.S. Public Offering
October 15, 2015
Nordic Nanovector adapts clinical development plan for Betalutin® in Follicular Lymphoma